243 related articles for article (PubMed ID: 22962576)
1. Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.
Lee SJ; Lee EJ; Kim SK; Jeong P; Cho YH; Yun SJ; Kim S; Kim GY; Choi YH; Cha EJ; Kim WJ; Moon SK
PLoS One; 2012; 7(9):e40267. PubMed ID: 22962576
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-28A triggers wound healing migration of bladder cancer cells via NF-κB-mediated MMP-9 expression inducing the MAPK pathway.
Lee SJ; Lim JH; Choi YH; Kim WJ; Moon SK
Cell Signal; 2012 Sep; 24(9):1734-42. PubMed ID: 22560878
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression.
Lee EJ; Lee SJ; Kim S; Cho SC; Choi YH; Kim WJ; Moon SK
Cell Signal; 2013 Oct; 25(10):2025-38. PubMed ID: 23770289
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-20 promotes migration of bladder cancer cells through extracellular signal-regulated kinase (ERK)-mediated MMP-9 protein expression leading to nuclear factor (NF-κB) activation by inducing the up-regulation of p21(WAF1) protein expression.
Lee SJ; Cho SC; Lee EJ; Kim S; Lee SB; Lim JH; Choi YH; Kim WJ; Moon SK
J Biol Chem; 2013 Feb; 288(8):5539-52. PubMed ID: 23271730
[TBL] [Abstract][Full Text] [Related]
5. Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells.
Lee SJ; Kim WJ; Moon SK
Int J Mol Med; 2012 Oct; 30(4):945-52. PubMed ID: 22825757
[TBL] [Abstract][Full Text] [Related]
6. p21WAF1 mediates the IL-15-induced migration and invasion of human bladder cancer 5637 cells via the ERK1/2/NF-κB/MMP-9 pathway.
Park SL; Kim WJ; Moon SK
Int Immunopharmacol; 2014 Sep; 22(1):59-65. PubMed ID: 24953855
[TBL] [Abstract][Full Text] [Related]
7. IL-5-induced migration via ERK1/2-mediated MMP-9 expression by inducing activation of NF-κB in HT1376 cells.
Lee EJ; Park SS; Kim WJ; Moon SK
Oncol Rep; 2012 Sep; 28(3):1084-90. PubMed ID: 22710862
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
Zhang H; Shan G; Song J; Tian Y; An LY; Ban Y; Luo GH
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391563
[TBL] [Abstract][Full Text] [Related]
9. A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer.
Piao XM; Kang HW; Jeong P; Byun YJ; Lee HY; Kim K; Seo SP; Kim WT; Lee JY; Ha YS; Choi YH; Moon SK; Yun SJ; Kim WJ
Urol Oncol; 2021 Apr; 39(4):237.e21-237.e29. PubMed ID: 33339725
[TBL] [Abstract][Full Text] [Related]
10. An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
You J; Madigan MC; Rowe A; Sajinovic M; Russell PJ; Jackson P
Urol Oncol; 2012; 30(4):502-8. PubMed ID: 20864363
[TBL] [Abstract][Full Text] [Related]
11. Dynamic expression changes between non-muscle-invasive bladder cancer and muscle-invasive bladder cancer.
Zhao YG; Shi BY; Qian YY; Bai HW; Xiao L; He XY
Tumori; 2014; 100(6):e273-81. PubMed ID: 25688510
[TBL] [Abstract][Full Text] [Related]
12. Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells.
Piao XM; Hwang B; Jeong P; Byun YJ; Kang HW; Seo SP; Kim WT; Lee JY; Ha YS; Lee YS; Kim IY; Choi YH; Cha EJ; Moon SK; Yun SJ; Kim WJ
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982770
[TBL] [Abstract][Full Text] [Related]
13. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.
Park SL; Cho TM; Won SY; Song JH; Noh DH; Kim WJ; Moon SK
Oncol Rep; 2015 Sep; 34(3):1605-12. PubMed ID: 26166554
[TBL] [Abstract][Full Text] [Related]
15. High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
Wang JF; Gong YQ; He YH; Ying WW; Li XS; Zhou XF; Zhou LQ
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6605-6615. PubMed ID: 32633349
[TBL] [Abstract][Full Text] [Related]
16. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J
Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144
[TBL] [Abstract][Full Text] [Related]
17. Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.
Dong Q; Fu L; Zhao Y; Tan S; Wang E
Oncotarget; 2017 Mar; 8(10):17059-17069. PubMed ID: 28178653
[TBL] [Abstract][Full Text] [Related]
18. Morin Inhibits Proliferation, Migration, and Invasion of Bladder Cancer EJ Cells via Modulation of Signaling Pathways, Cell Cycle Regulators, and Transcription Factor-Mediated MMP-9 Expression.
Shin SS; Won SY; Noh DH; Hwang B; Kim WJ; Moon SK
Drug Dev Res; 2017 Mar; 78(2):81-90. PubMed ID: 28176369
[TBL] [Abstract][Full Text] [Related]
19. p27KIP1 is involved in ERK1/2-mediated MMP-9 expression via the activation of NF-κB binding in the IL-7-induced migration and invasion of 5637 cells.
Park SL; Lee EJ; Kim WJ; Moon SK
Int J Oncol; 2014 Apr; 44(4):1349-56. PubMed ID: 24504262
[TBL] [Abstract][Full Text] [Related]
20. rs3918242 variant genotype frequency and increased TIMP-2 and MMP-9 expression are positively correlated with cancer invasion in urinary bladder cancer.
Pençe S; Özbek E; Ozan Tiryakioğlu N; Ersoy Tunali N; Pençe HH; Tunali H
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):46-52. PubMed ID: 28980922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
